October 20, 2017 12:58 PM ET

Capital Markets

Company Overview of Lightstone Ventures

Company Overview

Lightstone Ventures is a venture capital firm specializing in early stage and selective later stage investments. The firm seeks to invest in life sciences, therapeutics focusing on biotech, biopharmaceutical, and medical devices companies. It seeks to invest in companies which will be incorporated outside the United States in Europe, Asia and also Australia. Lightstone Ventures was launched in 2012 and is based in Menlo Park, California with additional offices in Boulder, Colorado, Boston, Massachusetts, Dublin, Ireland and Singapore.

2884 Sand Hill Road

Suite 121

Menlo Park, CA 94025

United States

Founded in 2012





Key Executives for Lightstone Ventures

General Partner
Age: 59
General Partner
Age: 59
General Partner
Age: 79
General Partner and Team Leader
Age: 52
Chief Executive Officer of Singapore Office
Age: 69
Compensation as of Fiscal Year 2017.

Lightstone Ventures Key Developments

Lightstone Ventures Presents at 10th Annual International Partnering Conference BioPharm America, Sep-26-2017 through Sep-27-2017

Lightstone Ventures Presents at 10th Annual International Partnering Conference BioPharm America, Sep-26-2017 through Sep-27-2017. Venue: Sheraton Boston Hotel, Boston, Massachusetts, United States. Presentation Date & Speakers: Sep-26-2017, Anna Turetsky, Vice President. Sep-27-2017, Anna Turetsky, Vice President.

Lightstone Ventures Announces Partners Appointments

Lightstone Ventures announced that it has named Jason Lettmann as a General Partner, and Mark Deem and Hanson Gifford as Partners. The company led by a team of seasoned investors with a strong track record of success, including General Partners Mike Carusi, Jean George, Jason Lettmann, and Hank Plain.  The firm has strengthened its operational and technical depth with Partners Mark Deem and Hanson Gifford, Venture Partner Stacy Enxing Seng, and Scientific Advisor Susan Molineaux.  These individuals, collectively, have been involved in venture-backed exits in the life sciences industry including Ardian Inc.; Acceleron Pharma Inc.; Calithera Biosciences Inc.; Plexxikon Inc.; Portola Pharmaceuticals Inc.; Proteolix Inc.; Twelve Inc.; and ZELTIQ Aesthetics Inc.

Lightstone Ventures Presents at The Medtech Conference, Jun-01-2017

Lightstone Ventures Presents at The Medtech Conference, Jun-01-2017. Venue: The Loews Minneapolis Hotel, 601 1st Ave N, Minneapolis, MN 55403, United States. Presentation Date & Speakers: Jun-01-2017, Mark E. Deem, Venture Partner, Stacy Enxing Seng, Vice President and Venture Partner.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States
123Jump.com, Inc. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

Private Placement
October 17, 2017
Gemini Therapeutics, Inc.
Private Placement
September 19, 2017
Disarm Therapeutics, Inc.
Private Placement
June 30, 2017
Alexo Therapeutics Ltd

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Lightstone Ventures, please visit www.lightstonevc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.